Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19.
Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19.
复制标题
DOI：
10.1002/rcr2.801
复制
发表时间：
2021-07
影响因子：
0.8
通讯作者：
Kumanogoh A
中科院分区：
文献类型：
--
作者：
Amiya S;Hirata H;Shiroyama T;Adachi Y;Niitsu T;Noda Y;Enomoto T;Hara R;Fukushima K;Suga Y;Miyake K;Koide M;Uchiyama A;Takeda Y;Kumanogoh A
2019 冠状病毒病 (COVID-19) 可导致严重的淋巴细胞减少和呼吸衰竭，需要长时间有创机械通气 (MV)。患有严重淋巴细胞减少或呼吸衰竭的 COVID-19 患者有发生继发感染的风险。在此，我们介绍一名患有 COVID-19 的危重患者的针头尸检结果，该患者需要重新插管和延长 MV，最终死于继发性巨细胞病毒 (CMV) 肺炎。该病例强调了长期使用类固醇的潜在风险以及对 COVID-19 危重患者进行 CMV 感染常规监测的必要性。在此，我们介绍一名患有 2019 年冠状病毒病 (COVID-19) 的危重患者的针检结果，该患者需要重新插管和长时间机械通气，最终死于继发性巨细胞病毒 (CMV) 肺炎。该病例强调了长期使用类固醇的潜在风险以及对 COVID-19 危重患者进行 CMV 常规监测的必要性。
Coronavirus disease 2019 (COVID‐19) can cause severe lymphopenia and respiratory failure requiring prolonged invasive mechanical ventilation (MV). COVID‐19 patients with severe lymphopenia or respiratory failure are at risk of developing secondary infections. Here, we present the needle autopsy findings of a critically ill patient with COVID‐19 who required reintubation and prolonged MV, and eventually died of secondary cytomegalovirus (CMV) pneumonia. This case highlights the potential risk of long‐term steroid use and the need for routine monitoring for CMV infection in critically ill patients with COVID‐19. Here, we present the needle autopsy findings of a critically ill patient with coronavirus disease 2019 (COVID‐19) who required reintubation and prolonged mechanical ventilation, and eventually died of secondary cytomegalovirus (CMV) pneumonia. This case highlights the potential risk of long‐term steroid use and the need for routine monitoring for CMV in critically ill patients with COVID‐19.
登录
查看更多内容
影响因子：
15.9
作者：
Wang, Yanqun;Zhang, Lu;Zhao, Jincun
通讯作者：
Zhao, Jincun
DOI：
10.1016/j.cmi.2020.10.021
发表时间：
2021-03
期刊：
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子：
--
作者：
Ripa M;Galli L;Poli A;Oltolini C;Spagnuolo V;Mastrangelo A;Muccini C;Monti G;De Luca G;Landoni G;Dagna L;Clementi M;Rovere Querini P;Ciceri F;Tresoldi M;Lazzarin A;Zangrillo A;Scarpellini P;Castagna A;COVID-BioB study group
通讯作者：
COVID-BioB study group
DOI：
10.4084/mjhid.2020.060
发表时间：
2020-09-01
影响因子：
3.2
作者：
Marchi, Giacomo;Vianello, Alice;Girelli, Domenico
通讯作者：
Girelli, Domenico
影响因子：
38.9
作者：
Ong DSY;Spitoni C;Klein Klouwenberg PMC;Verduyn Lunel FM;Frencken JF;Schultz MJ;van der Poll T;Kesecioglu J;Bonten MJM;Cremer OL
通讯作者：
Cremer OL
影响因子：
8.8
作者：
Cook, CH;Martin, LC;Ferguson, RM
通讯作者：
Ferguson, RM